AC Immune SA (ACIU)
3.00
+0.16
(+5.63%)
USD |
NASDAQ |
Nov 01, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
AC Immune Price: 3.00 for Nov. 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 01, 2024 | 2.86 | 3.00 | 2.85 | 3.00 | 73043.00 |
| Oct 31, 2024 | 2.89 | 2.97 | 2.80 | 2.84 | 96967.00 |
| Oct 30, 2024 | 2.97 | 3.015 | 2.97 | 2.97 | 66704.00 |
| Oct 29, 2024 | 3.04 | 3.04 | 2.95 | 3.01 | 40257.00 |
| Oct 28, 2024 | 3.05 | 3.12 | 2.95 | 3.00 | 73391.00 |
| Oct 25, 2024 | 3.00 | 3.09 | 2.99 | 3.05 | 46247.00 |
| Oct 24, 2024 | 3.08 | 3.10 | 2.99 | 3.00 | 86828.00 |
| Oct 23, 2024 | 3.14 | 3.232 | 2.92 | 3.04 | 136932.0 |
| Oct 22, 2024 | 3.04 | 3.15 | 3.02 | 3.11 | 129468.0 |
| Oct 21, 2024 | 3.14 | 3.240 | 3.03 | 3.07 | 123784.0 |
| Oct 18, 2024 | 3.26 | 3.365 | 3.06 | 3.13 | 122281.0 |
| Oct 17, 2024 | 3.21 | 3.22 | 3.18 | 3.21 | 54198.00 |
| Oct 16, 2024 | 3.20 | 3.27 | 3.17 | 3.19 | 85546.00 |
| Oct 15, 2024 | 3.19 | 3.28 | 3.19 | 3.20 | 60430.00 |
| Oct 14, 2024 | 3.36 | 3.39 | 3.13 | 3.19 | 106413.0 |
| Oct 11, 2024 | 3.30 | 3.344 | 3.28 | 3.32 | 44969.00 |
| Oct 10, 2024 | 3.33 | 3.39 | 3.29 | 3.34 | 51101.00 |
| Oct 09, 2024 | 3.31 | 3.459 | 3.31 | 3.39 | 62689.00 |
| Oct 08, 2024 | 3.45 | 3.45 | 3.31 | 3.31 | 21512.00 |
| Oct 07, 2024 | 3.41 | 3.53 | 3.35 | 3.40 | 50961.00 |
| Oct 04, 2024 | 3.43 | 3.50 | 3.32 | 3.38 | 72025.00 |
| Oct 03, 2024 | 3.49 | 3.515 | 3.32 | 3.39 | 88707.00 |
| Oct 02, 2024 | 3.74 | 3.75 | 3.46 | 3.48 | 95758.00 |
| Oct 01, 2024 | 3.84 | 3.84 | 3.66 | 3.75 | 120650.0 |
| Sep 30, 2024 | 3.56 | 3.82 | 3.54 | 3.78 | 91891.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.72
Minimum
Dec 22 2022
9.89
Maximum
Jan 15 2020
4.752
Average
4.095
Median
Price Benchmarks
| CRISPR Therapeutics AG | 50.76 |
| Addex Therapeutics Ltd | 10.70 |
| NLS Pharmaceutics Ltd | 3.60 |
| Molecular Partners AG | 6.12 |
| MoonLake Immunotherapeutics | 46.76 |
Price Related Metrics
| Price to Book Value | 2.162 |
| Price to Free Cash Flow | 5.768 |
| Earnings Yield | -24.02% |
| Market Cap | 296.82M |